(Q34741024)

English

Mass media release of medical research results: an analysis of antihypertensive drug prescribing in the aftermath of the calcium channel blocker scare of March 1995

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Mass media release of medical research results: an analysis of antihypertensive drug prescribing in the aftermath of the calcium channel blocker scare of March 1995 (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

based on heuristic

inferred from title

3

object named as

Siu L Hui

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

author name string

Margaret E Brunt

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Michael D Murray

2

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Joseph Kesterson

4

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Anthony J Perkins

5

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

William M Tierney

6

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

publication date

1 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Journal of General Internal Medicine

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

84-94

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Medical scientists and health news reporting: a case of miscommunication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494819

7 July 2018

The Ingelfinger rule, embargoes, and journal peer review--part 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494819

7 July 2018

The Ingelfinger rule, embargoes, and journal peer review--Part 1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494819

7 July 2018

Reporting research in medical journals and newspapers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494819

7 July 2018

Nifedipine. Dose-related increase in mortality in patients with coronary heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494819

7 July 2018

The Risk of Myocardial Infarction Associated With Antihypertensive Drug Therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494819

7 July 2018

No magic bullets: a systematic review of 102 trials of interventions to improve professional practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494819

7 July 2018

Doxazosin for the treatment of benign prostatic hyperplasia in patients with mild to moderate essential hypertension: a double-blind, placebo-controlled, dose-response multicenter study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494819

7 July 2018

Doxazosin in the treatment of benign prostatic hyperplasia in normotensive patients: a multicenter study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494819

7 July 2018

The Ingelfinger Rule

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494819

7 July 2018

Importance of the lay press in the transmission of medical knowledge to the scientific community

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494819

7 July 2018

The Ingelfinger Rule revisited.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494819

7 July 2018

A Randomized, Placebo-Controlled Multicenter Study of the Efficacy and Safety of Terazosin in the Treatment of Benign Prostatic Hyperplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494819

7 July 2018

Sensationalism and the news media

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2003.20502.X

21 January 2018

A new look at the statistical model identification

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2003.20502.X

21 January 2018

Medical journals and society: threats and responsibilities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1494819

26 October 2018

Early release of research results

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2003.20502.X

21 January 2018

The calcium channel blocker scare. Lessons for the future

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2003.20502.X

21 January 2018

The impact of media coverage on practice

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2003.20502.X

21 January 2018

Influences of educational interventions and adverse news about calcium-channel blockers on first-line prescribing of antihypertensive drugs to elderly people in British Columbia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2003.20502.X

21 January 2018

The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)

1 reference

https://pubmed.ncbi.nlm.nih.gov/12542582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12542582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Definition of Sole Contribution

1 reference

https://pubmed.ncbi.nlm.nih.gov/12542582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1046/J.1525-1497.2003.20502.X

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34741024&oldid=2196997717"